Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest

被引:509
|
作者
Pigny, P
Merlen, E
Robert, Y
Cortet-Rudelli, C
Decanter, C
Jonard, S
Dewailly, D
机构
[1] CHRU, Hop Jeanne Flandre, Dept Endocrine Gynaecol & Reprod Med, F-59037 Lille, France
[2] CHRU, Clin Marc Linquette, Lab Endocrinol, F-59037 Lille, France
[3] CHRU, Hop Jeanne Flandre, Dept Radiol, F-59037 Lille, France
[4] CHRU, Dept Diabetol & Endocrinol, F-59037 Lille, France
来源
关键词
D O I
10.1210/jc.2003-030727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The serum level of anti-Mullerian hormone (AMH), a product from granulosa cells involved in follicle growth, has been shown to correlate tightly with the small antral follicle number (FN) at ultrasonography (U/S) in women who do not have polycystic ovary syndrome ( PCOS). Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS. Serum AMH has been assayed in 104 women ( 59 symptomatic PCOS, 45 controls) between d 2 and 7 after the last either spontaneous or progestin-induced ( in PCOS) menstrual period. Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively). The ratio AMH/FN was similar between the two groups (4.8 +/- 3.4 vs. 4.8 +/- 2.9; P = 0.55). By simple regression, both in PCOS and controls, the AMH level was positively related to the 2- to 5-mm FN at U/S (P < 0.0001 and P < 0.03, respectively), but not to the 6- to 9-mm FN, and was negatively correlated to the serum FSH level ( P < 0.02 and P < 0.04, respectively). AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively ( P < 0.0005 and < 0.002, respectively). No relationship was found between AMH and age, serum estradiol, inhibin B, and LH levels in both groups. After multiple regression only the 2- to 5-mm FN remained significantly related to AMH in PCOS whereas testosterone, androstenedione, and FSH were no longer. In conclusion, the assay of the serum AMH may represent an important breakthrough in the diagnosis and in the understanding of PCOS. Our data suggest that the increase of AMH serum level in PCOS is the consequence of the androgen-induced excess in small antral FN and that each follicle produces a normal amount of AMH. We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.
引用
收藏
页码:5957 / 5962
页数:6
相关论文
共 50 条
  • [41] Anti-Mullerian hormone reflects the severity of polycystic ovary syndrome
    Jacob, S. L.
    Field, H. P.
    Calder, N.
    Picton, H. M.
    Balen, A. H.
    Barth, J. H.
    CLINICAL ENDOCRINOLOGY, 2017, 86 (03) : 395 - 400
  • [42] Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome
    Kohzadi, Mozhgan
    Khazaei, Mohammad Rasool
    Choobsaz, Farzaneh
    Khazaei, Mozafar
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2020, 14 (01) : 27 - 33
  • [43] Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women
    Wachs, Deborah S.
    Coffler, Mickey S.
    Malcom, Pamela J.
    Chang, R. Jeffrey
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05): : 1871 - 1874
  • [44] Elevated serum levels of anti-Mullerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome
    Sahmay, Sezai
    Atakul, Nil
    Aydogan, Begum
    Aydin, Yavuz
    Imamoglu, Metehan
    Seyisoglu, Hakan
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2013, 92 (12) : 1369 - 1374
  • [45] Effect of anti-mullerian hormone on stem cell factor in serum, follicular fluid and ovarian granular cells of polycystic ovarian syndrome patients
    Zhang, J-F
    Yu, C-M
    Yan, L-L
    Ma, J-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) : 7877 - 7882
  • [46] Anti-Mullerian hormone measurement for the diagnosis of polycystic ovary syndrome
    Sathyapalan, Thozhukat
    Al-Qaissi, Ahmed
    Kilpatrick, Eric S.
    Dargham, Soha R.
    Atkin, Stephen L.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (02) : 258 - 262
  • [47] The phenotypic diversity in per-follicle anti-Mullerian hormone production in polycystic ovary syndrome
    Alebic, M. S.
    Stojanovic, N.
    Duhamel, A.
    Dewailly, D.
    HUMAN REPRODUCTION, 2015, 30 (08) : 1927 - 1933
  • [48] Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan
    Tremellen, Kelton
    Zander-Fox, Deidre
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2015, 55 (04): : 384 - 389
  • [49] The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
    Moursi, Moaz O.
    Salem, Haya
    Ibrahim, Ayman R.
    Marzouk, Sandy
    Al-Meraghi, Sara
    Al-Ajmi, Maha
    Al-Naimi, Alreem
    Alansari, Lolwa
    GYNECOLOGICAL ENDOCRINOLOGY, 2023, 39 (01)
  • [50] Salivary and serum androgens with anti-Mullerian hormone measurement for the diagnosis of polycystic ovary syndrome
    Sathyapalan, Thozhukat
    Al-Qaissi, Ahmed
    Kilpatrick, Eric S.
    Dargham, Soha R.
    Keevil, Brian
    Atkin, Stephen L.
    SCIENTIFIC REPORTS, 2018, 8